Related Experiment Video
Updated: Dec 6, 2025

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
Comprehensive multi-factor analysis and exploration for the pathogenesis of non-ischemic cardiomyopathy and ischemic
Fengling Li1, Lin Cheng1, Lin Ma1
1Department of Cardiology, Shan Xian Central Hospital, Shandong 274300, China.
Insights
This study identifies key genes and regulatory factors driving both non-ischemic and ischemic cardiomyopathy. Understanding these core pathogenic drivers improves insights into heart disease mechanisms.
Area of Science:
- Genomics and Molecular Biology
- Cardiovascular Research
- Systems Biology
Background:
- Cardiomyopathy encompasses diverse heart diseases impacting cardiac function.
- While progress has been made, the precise molecular mechanisms of cardiomyopathy pathogenesis remain unclear.
- Distinguishing between non-ischemic and ischemic cardiomyopathy is crucial for understanding disease drivers.
Purpose of the Study:
- To modularize the pathogenesis of non-ischemic and ischemic cardiomyopathy.
- To identify common core pathogenic driver genes shared between these cardiomyopathy types.
- To uncover potential regulatory factors, including non-coding RNAs and transcription factors, involved in cardiomyopathy.
Main Methods:
- Differential gene expression analysis on patient data.
- Co-expression network analysis to identify gene modules.
- Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis.
- Hypergeometric tests to predict regulatory non-coding RNAs (ncRNAs) and transcription factors (TFs).
Main Results:
- Identified 8 co-expression modules, highlighting HN1 and PRDX3 as key genes in cardiomyopathy pathogenesis.
- Module genes are significantly involved in neutrophil-mediated immune responses and pathways like Vibrio cholerae infection.
- Identified key regulatory ncRNAs (e.g., MALAT1, miR-133a-3p) and TFs (e.g., NFKB1, RELA).
Conclusions:
- Decoded a co-expression network central to non-ischemic and ischemic cardiomyopathy.
- Discovered core dysfunction modules and potential regulatory factors driving cardiomyopathy.
- Enhanced understanding of the molecular pathogenesis of cardiomyopathy, aiding future therapeutic strategies.
Abstract:
Cardiomyopathy is a group of heterogeneous diseases that negatively affect cardiac function. Twenty-five years ago, clinical researchers began to realize that cardiomyopathy is an important and fairly common heart disease. Although many aspects of the pathogenesis of cardiomyopathy have been explored by biologists, the molecular mechanisms remain elusive. This study modularized the pathogenesis of non-ischemic cardiomyopathy and ischemic cardiomyopathy and finally explored their common core pathogenic driver genes. First, based on the normal expression profile data of patients with non-ischemic cardiomyopathy and ischemic cardiomyopathy, differential expression analysis was used to screen differentially expressed genes. Secondly, the co-expression analysis of differentially expressed genes was performed to obtain a co-expression module of genes. Thirdly, the enrichment analysis of GO functions and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was conducted on the module genes. Finally, based on hypergeometric tests, non-coding RNA (ncRNA) and transcription factors with significant regulatory effects were predicted. In summary, we obtained 8 co-expression modules, of which HN1, PRDX3 genes had significant differences in expression in patients with cardiomyopathy, and had a positive regulatory role in the dysfunction module, so they were recognized as non-ischemic and key genes for non-ischemic diseases and ischemic cardiomyopathy. The enrichment results showed that the module genes were significant in the biological processes of neutrophil activation involved in immunoreaction, neutrophil-mediated immunity, neutrophil activation, and neutrophil degranulation, and significantly regulate the signal pathways such as vibrio cholerae infection. Finally, significant regulatory dysfunction modules of pivot ncRNAs (including MALAT1, miR-133a-3p, and miR-133b) and pivot TFs (including NFKB1, PML, and RELA, etc.) were identified. In summary, our work decodes a co-expression network involving the regulation of key genes in non-ischemic and ischemic cardiomyopathy. It helps to discover core dysfunction modules and potential regulatory factors, drive disease genes, and improve our understanding of its pathogenesis.
More Related Videos
03:45Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
12:24Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy